About Charley's fund
Charley's Fund: Accelerating the Development of Life-Saving Treatments for Duchenne Muscular Dystrophy
Charley's Fund is a non-profit organization that is dedicated to accelerating the development of life-saving treatments for Duchenne muscular dystrophy (DMD). This debilitating disease affects approximately 1 in every 3,500 boys worldwide and is caused by a genetic mutation that leads to progressive muscle weakness and wasting. Charley's Fund was founded in 2004 by Tracy and Benjamin Seckler, parents of Charley Seckler who was diagnosed with DMD at the age of two.
The mission of Charley's Fund is to support research into potential treatments for DMD, as well as to advocate for policies that will help accelerate the development and approval of these treatments. The organization has been instrumental in funding groundbreaking research into gene therapy, exon skipping, and other promising approaches to treating this devastating disease.
One of the key initiatives supported by Charley's Fund is its collaboration with leading researchers around the world through its CureDuchenne Ventures program. This program provides funding and resources to help advance promising therapies from early-stage research through clinical trials and ultimately FDA approval. Through this program, Charley's Fund has helped bring several new therapies closer to market, including gene therapy approaches that have shown remarkable promise in preclinical studies.
In addition to supporting cutting-edge research into potential treatments for DMD, Charley's Fund also works tirelessly on behalf of families affected by this disease. The organization provides resources and support services designed specifically for families dealing with DMD diagnosis or caring for loved ones with this condition. These services include educational materials about treatment options, financial assistance programs designed specifically for families affected by rare diseases like DMD, advocacy efforts aimed at improving access to care and treatment options.
Charley’s fund also supports solutions aimed at translating scientific promise into real-world results. One such initiative is its Duchenne Drug Development Roundtable, which brings together leading researchers, clinicians, and industry experts to discuss the latest developments in DMD research and identify opportunities for collaboration. Through this program, Charley's Fund has helped foster a more collaborative and coordinated approach to DMD research that is helping accelerate the development of new treatments.
Overall, Charley's Fund is an organization that is making a real difference in the lives of families affected by Duchenne muscular dystrophy. Through its innovative research programs, advocacy efforts, and support services for families dealing with this disease, Charley's Fund is helping to accelerate the development of life-saving treatments for DMD while also providing much-needed support to those affected by this condition. If you are looking for a way to make a difference in the fight against Duchenne muscular dystrophy or want to learn more about how you can support Charley's Fund’s mission please visit their website today!
charleysfund.org